Skip to main content
Equibles
PAXH logo

PAXH · Preaxia Health Care Payment Systems Inc. · Metrics

Track PAXH — free

Use PAXH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PAXH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.22 At close · Sep 18
Rebalance outlook locked
Going-concern doubt — flagged Oct 15, 2026

Substantial doubt about the company's ability to continue as a going concern.

“During the three months ended August 31, 2026, the Company incurred a net comprehensive loss of ($220,616) and provided cash in operating activities of $22,096, and as of August 31, 2026, had a stockholders' deficit of ($543,336) and an accumulated deficit of ($6,578,737). These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern within one year of the date that the consolidated financial statements are issued. The Company's consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty should we be unable to continue as a going concern.”
View the 10-Q filed Oct 15, 2026
Market Cap
$10.63M
Shares
48.31M
Volume · Sep 18 1000 Avg daily vol (7 sessions) 32.56K

PAXH metrics

36 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.22
Market cap
$10.63M

Price action

20 metrics
Price change (1W)
—
Price change (30D)
—
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
—
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
48.31M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
-4.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-5.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
$0
Operating profit (TTM)
−$616,974
Net income (TTM)
−$619,273
Trailing 12 months
Diluted EPS (TTM)
$-0.01
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-0.01
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-0.01
Operating cash flow per diluted share (TTM)
$0.00
Free cash flow per diluted share (TTM)
$-0.01
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
$0.00
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.01

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+34.8%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-74.1%
Debt / equity
—
Current ratio
0.1
EBITDA (TTM)
−$583,326
Free cash flow (TTM)
−$446,150
Quick ratio
0.1
Interest coverage
-90.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$52,704
Latest balance sheet
Cash & equivalents
$141,579
Total assets
$836,203
Total debt
$88,875

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$24,258
Capital expenditures (TTM)
$421,892
R&D (TTM)
$0
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1350156 Visit website Investor relations